Burnasyan Federal Medical Biophysical Center of Federal Medical-Biological Agency of Russia, Moscow, Russia.
Russian Biotechnological University (BIOTECH University), Moscow, Russia.
Bull Exp Biol Med. 2024 Mar;176(5):572-575. doi: 10.1007/s10517-024-06069-0. Epub 2024 May 10.
A comparative assessment of radioprotective properties of inosine nucleoside (riboxin) and recognized radioprotector indralin was carried out. We analyzed survival of male ICR CD-1 mice weighting 32.2±0.2 g exposed to external X-ray radiation at doses 6.5 and 6.75 Gy and receiving indralin at a dose of 100 or 150 μg/g body weight or riboxin (inosine) at a dose of 100 or 200 μg/g body weight before irradiation. The survival analysis was carried out by the Kaplan-Meier method. The significance was assessed by using the log-rank-test. Inosine showed a significant difference from the irradiated control only at a dose of 100 μg/g body weight at a radiation dose of 6.75 Gy. The survival of animals treated with indralin was significantly higher in comparison with not only the irradiated control group, but also with the groups receiving inosine.
我们对肌苷核苷(核糖核酸)和公认的放射保护剂吲达林的放射防护性能进行了比较评估。我们分析了体重为 32.2±0.2 g 的雄性 ICR CD-1 小鼠在接受 6.5 和 6.75 Gy 外照射辐射后,以及在照射前接受 100 或 150 μg/g 体重的吲达林或 100 或 200 μg/g 体重的肌苷核苷(肌苷)时的存活情况。采用 Kaplan-Meier 法进行生存分析。使用对数秩检验评估显著性。仅在 6.75 Gy 辐射剂量下,肌苷核苷在 100 μg/g 体重剂量时与照射对照组相比显示出显著差异。与照射对照组以及接受肌苷核苷的组相比,接受吲达林治疗的动物的存活率显著更高。